Company Long-Term Loans and Borrowings: Aquestive Pharma (AQST)

Public company logo of Aquestive Pharma (AQST)

Current price action for Aquestive Therapeutics (AQST) on GURU.Markets is comparable to the 0.00 metric. The business relies on unique PharmFilm soluble films for injection-free CNS and allergy therapies. However, global conflicts and sanctions complicate product export and registration. To mitigate risks, Aquestive Therapeutics (AQST) is expanding its network of third-party manufacturing plants to ensure stable drug production.

AQST Aquestive Therapeutics Company Long-Term Debts (07/04/2022 - 10/31/2026)

Summary analytical data breakdowns for Aquestive Pharma (AQST)

- market price and analyst price targets:
Stock Price aquestive.com|AQST - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Aquestive Therapeutics|AQST - Total Company Value
- book capitalization information:
Accounting Value per Share Aquestive Therapeutics|AQST - Book Capitalization|Market Capitalization to Book Value Ratio aquestive.com|AQST - Cumulative Company Assets
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Aquestive Therapeutics|AQST - Long-Term Debt to Equity|Current Liabilities to Capital Aquestive Corp|AQST - Company Total Debt|Debt to Book Capital Aquestive Therapeutics|AQST - Company Long-Term Debts|Company Short-Term Loans and Borrowings Aquestive Therapeutics|Immediate Liquidity aquestive.com
- earnings and multiples data:
AQST - Company Net Income
Fundamental company valuation:aquestive.com AQST
Brand item of Aquestive Therapeutics, Inc.

This indicator measures the total volume of credit obligations with a maturity of more than one year, allowing for an assessment of long-term financial stability and the cost of servicing borrowed capital. By analyzing the company's long-term debt, investors determine the liquidity shortage risk for Aquestive Therapeutics (AQST), which is critical for a pharmaceutical business during the period of awaiting regulatory approvals and fighting for patent protection.

Who Aquestive Therapeutics competes with

Company Long-Term Debts haleon.com HLN|KVUE - Company Long-Term Debt|Company Long-Term Loans and Borrowings VRNA (Verona Pharma PLC)|Jyong Biotech Corp (MENS) - Company Long-Term Debt|Company Long-Term Liabilities Ligand Corp|AMRX (Amneal Pharmaceuticals) - Company Long-Term Debts|Company Long-Term Debts perrigo.com|Company Long-Term Liabilities ALVO (Alvotech SA)|LQDA (Liquidia Corp) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Galapagos Genomics GLPG|ANI Pharmaceuticals Corp (ANIP) - Long-Term Debt|MNKD: Company Long-Term Liabilities|amphastar.com - Amount of Long-Term Liabilities|PCRX: Company Long-Term Debts|ARS Pharmaceuticals Inc - Company Long-Term Loans and Borrowings|TBPH (Theravance) - Company Long-Term Debts|Long-Term Debt scPharma SCPH|Company Long-Term Debt Tectonic Therapeutic, Inc. (TECX)|TNXP (tonixpharma.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debts SXTC (China SXT Pharmaceuticals, Inc.)|Company Long-Term Debts Eupraxia Pharmaceuticals, Inc. EPRX|BHST - Company Long-Term Debt|Long-Term Indebtedness Invizyne (EXOZ)|ORMP (oramed.com) - Company Long-Term Liabilities|Entera Bio (ENTX) - Company Long-Term Debts|HYFT (MindWalk Holdings Inc.) - Company Long-Term Debts|Long-Term Debt ABVC BioPharma Inc. ABVC|Company Long-Term Debt Cumberland Pharma (CPIX)|Long-Term Debt Volume Quantum BioPharma Corp|FibroGen, Inc. - Company Long-Term Liabilities|Amount of Long-Term Liabilities TELO (telomirpharma.com)|Rani Therapeutics Inc - Company Long-Term Debts|Long-Term Debt Volume Synergy CHC Corp SNYR|RLYB (rallybio.com) - Company Long-Term Liabilities|LEXX (Lexaria Bioscience Corp.) - Company Long-Term Debt|PULM (Pulmatrix, Inc.) - Company Long-Term Debts|Long-Term Debt Pheton PTHL|Company Long-Term Liabilities APM (Aptorum Group Limited)|LYRA (Lyra Therapeutics Inc.) - Company Long-Term Loans and Borrowings|Impact BioMedical Inc - Company Long-Term Liabilities|Amount of Long-Term Liabilities TNFA (TNF Pharmaceuticals Inc.)|cbdMD Corp - Company Long-Term Debts|Company Long-Term Loans and Borrowings PRFX (painreform.com)|CYTO: Company Long-Term Debts|Long-Term Debt Lipella Pharmaceuticals Inc (LIPO)|Company Long-Term Debt Optinose|PIRS: Company Long-Term Loans and Borrowings|Company Long-Term Debts PROC|Company Long-Term Debts petrospharma.com (PTPI)|Company Long-Term Debt Qilian International Holding QLI|SLRN (Acelyrin Inc.) - Long-Term Liabilities|TFF Pharma - Company Long-Term Debts